Switch of Renin-Angiotensin System Inhibitors in Patients With Covid-19
Status:
Terminated
Trial end date:
2021-09-28
Target enrollment:
Participant gender:
Summary
The SWITCH-COVID trial will randomize patients with COVID-19 that are currently using
renin-angiotensin system inhibitors for treating hypertension to maintain the therapy during
in-hospital stay or switch the therapy to other antihypertensive classes.